Article Menu

Export Article

More by Authors Links

Article Data

  • Views 300
  • Dowloads 120

Original Research

Open Access

Familial and hormonal risk factors for papillary serous uterine cancer

  • L. Elit1,2,6,*,
  • T. Pal6
  • R. Goshen2
  • H. Jernstrom6,7
  • I. Ackerman5
  • A. Fyles4
  • M. Carey3
  • M. Mitchell6
  • J. Aube6
  • S. A. Narod6

1Departments of Obstetrics and Gynecology, McMaster University Hamilton, Canada

2University ofTm-onto, Toronto, Canada

3University of Western Ontario, London, Divisions of Radiation Oncology, Sweden

4Princess Margaret Hospital, Canada

5Toronto-Bayview Regional Cancer Centre, Toronto, Canada

6Centre for Research in Wrmien's Health, Toronto, Canada

7The Jubileum Institute, Department of Oncology, Lund University Hospital, Sweden

DOI: 10.12892/ejgo200203187 Vol.23,Issue 3,May 2002 pp.187-190

Published: 10 May 2002

*Corresponding Author(s): L. Elit E-mail:

PDF (524.29 kB)

Abstract

Objectives: To identify genetic and non-genetic risk factors for papillary serous uterine cancer.

Methods: A case-control study was conducted. Case women with papillary serous uterine cancer were compared with two control groups: 1) women with endometrioid uterine cancer and 2) healthy women with no past history of cancer. Cases and controls were matched for age (within two years) and ethnic group. All study subjects completed a questionnaire addressing family history. The cases and healthy controls were assessed for factors associated with estrogen exposure.

Results: The risks of breast cancer (RR 1.84, CI 1.03-3.31) and of prostate cancer (RR 2.21, CI 0.77-6.37) were higher among the relatives of patients with papillary serous uterine cancer, than among relatives of those with endometrioid uterine cancer. Other significant risk factors included weight at 18 years (p = 0.04) and the use of estrogen replacement therapy (p = 0.04).

Conclusion: Relatives of women with papillary serous cancer of the uterus had an increased risk of breast and prostate cancer. Hormonal exposure also increases the risk for this cancer. These findings suggest that predisposing genetic factors, possibly related to hormone metabolism, may be common to the three forms of cancer.

Keywords

Hormonal risk factors; Papillary serous uterine cancer


Cite and Share

L. Elit,T. Pal,R. Goshen,H. Jernstrom,I. Ackerman,A. Fyles,M. Carey,M. Mitchell,J. Aube,S. A. Narod. Familial and hormonal risk factors for papillary serous uterine cancer. European Journal of Gynaecological Oncology. 2002. 23(3);187-190.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200203187

References

[1] Magri pies U., Naftolin F., Schwatrz P. E., Carcangiu M. L.: "Highgrade endometrial carcinoma in tarnoxifen-treated breast cancer patients". J. Clin. Oncol., 1993, 11, 485.

[2] Silva E. G., Tornos C., Malpica A., Mitchell M. F.:''Uterine neoplasrns in patients treated with tamoxifen". J. Cellular Biochern., 1995, 23, 179.

[3] Moslehi R., Chu W., Karlan B. Y., Fishman D. A., Risch H., Fields A. L. A. et al.:'·BRCA 1 and BRCA2 analy、is of 208 A、hkenazi Jewish women with ovarian cancer". Arn. J. Hurn. Genet. (in press)

[4] Aziz S. Kuperstein G. Rosen 13. McLaughlin J, Narod S A genetic epiderniologic study of fallopian tube cancer. Gynecol Oncol. in press.

[5] Kaplan E. J., Caputo T. A., Shen P. U. F.. Sassoon R. L Soslow R A.: "Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case". Gynecol. On col., 1998, 70, 289.

[6] Hornreich G., Beller U., Lavie 0., Renbaurn.P, Cohen Y., LevyLahad E.: "Is uterine pap仆lary carcinoma a BRCA L-related disease? Case report and review of the literature". Gynecol. Oncol., 1999, 75, 300.

[7] Go、hen R.. Chu W.. Elit L., Pal T., Hakiirni J., Ackerman I. et al: ''ls uterine papillary serous adenocarcinoma a manifestation of the Hereditary Breast-Ovarian Cancer Syndrome". Gynecl. Oncol., 2000, 79, 477.

[8] Sherrna'n M. E., Sturgeon S.. Brinton L. A.. Potischman N .. Kurman R. J., Berman M. L. et al.: "Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas". Mod. Pathol.. 1997, 10, 963.

[9] Gruber S. B., Thompson W. D.: "A population-based study of endometrial cancer and familial risk in younger women". Cancer Epidemiol., Biornark. and Preven., 1996, 5, 411.

[10] Parazinni F..La Vecchia C.、Moroni S.. Chatenoud L., Ricci E.: "F amily history and the risk of endometrial cancer". Int. J. Cancer, 1994, 59, 460.

[11] Bergman L., Beelen M. L. R., Gallee M. P. W., Hollema H.. Benraadt J., van Leeuwen F. E., ALERT Group: "Risk and prognosis of endometrial cancer after tamoxifen for breast cancer". Lancet, 2000, 356, 881.

[12] Narod S. A., Pal T., Graham T., Mitchell M.: "Fyles a letter to the editor: Tamoxifen and risk of endometrial cancer". Lancet, 2001. 357, 65.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top